Concepts (261)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Vagus Nerve Stimulation | 9 | 2022 | 229 | 2.150 |
Why?
|
Intracranial Thrombosis | 3 | 2021 | 108 | 1.230 |
Why?
|
Fibrin | 5 | 2021 | 515 | 1.200 |
Why?
|
Infarction, Middle Cerebral Artery | 4 | 2012 | 488 | 0.760 |
Why?
|
Tetanus Toxin | 6 | 2009 | 46 | 0.690 |
Why?
|
Cerebral Infarction | 3 | 2014 | 983 | 0.640 |
Why?
|
Brain Ischemia | 6 | 2017 | 3038 | 0.580 |
Why?
|
Rats, Wistar | 15 | 2014 | 1891 | 0.570 |
Why?
|
Positron-Emission Tomography | 6 | 2021 | 6657 | 0.500 |
Why?
|
Transcutaneous Electric Nerve Stimulation | 2 | 2019 | 170 | 0.470 |
Why?
|
Carotid Artery Thrombosis | 1 | 2014 | 50 | 0.470 |
Why?
|
Ear, External | 1 | 2014 | 165 | 0.450 |
Why?
|
Pterygopalatine Fossa | 1 | 2012 | 8 | 0.430 |
Why?
|
Rats | 25 | 2024 | 23839 | 0.420 |
Why?
|
Ganglia, Autonomic | 1 | 2012 | 43 | 0.420 |
Why?
|
Acetylcholine | 3 | 2006 | 629 | 0.400 |
Why?
|
Radiopharmaceuticals | 1 | 2021 | 2731 | 0.390 |
Why?
|
Cerebrum | 1 | 2012 | 132 | 0.380 |
Why?
|
Plaque, Atherosclerotic | 1 | 2021 | 1547 | 0.340 |
Why?
|
Kidney | 5 | 2024 | 7064 | 0.340 |
Why?
|
Vasodilation | 3 | 2004 | 968 | 0.320 |
Why?
|
Evans Blue | 1 | 2008 | 42 | 0.310 |
Why?
|
Nerve Endings | 2 | 2006 | 105 | 0.310 |
Why?
|
Peptide Fragments | 7 | 2009 | 5152 | 0.310 |
Why?
|
Molecular Imaging | 1 | 2014 | 825 | 0.280 |
Why?
|
Vagus Nerve | 3 | 2020 | 460 | 0.270 |
Why?
|
Synaptic Transmission | 1 | 2012 | 1173 | 0.270 |
Why?
|
Radioisotopes | 2 | 2021 | 516 | 0.270 |
Why?
|
Coloring Agents | 1 | 2008 | 564 | 0.260 |
Why?
|
Manganese | 2 | 2021 | 394 | 0.250 |
Why?
|
Renal Circulation | 1 | 2006 | 291 | 0.250 |
Why?
|
Calcitonin Gene-Related Peptide | 2 | 2006 | 329 | 0.240 |
Why?
|
Solitary Nucleus | 2 | 2015 | 54 | 0.240 |
Why?
|
Cortical Spreading Depression | 2 | 2020 | 288 | 0.230 |
Why?
|
Glial Cell Line-Derived Neurotrophic Factor | 3 | 2009 | 66 | 0.230 |
Why?
|
Cerebrovascular Circulation | 2 | 2012 | 2737 | 0.230 |
Why?
|
Adenoviridae | 1 | 2008 | 1098 | 0.230 |
Why?
|
Contrast Media | 6 | 2024 | 5336 | 0.220 |
Why?
|
Neurons, Afferent | 1 | 2006 | 498 | 0.220 |
Why?
|
Ischemic Attack, Transient | 1 | 2009 | 878 | 0.220 |
Why?
|
2-Aminoadipic Acid | 1 | 2023 | 32 | 0.220 |
Why?
|
Nephritis, Hereditary | 1 | 2023 | 78 | 0.210 |
Why?
|
Endothelium, Vascular | 4 | 2006 | 4425 | 0.210 |
Why?
|
Animals | 37 | 2024 | 169418 | 0.210 |
Why?
|
Heart Rate | 4 | 2019 | 4218 | 0.200 |
Why?
|
Aldehydes | 1 | 2023 | 170 | 0.200 |
Why?
|
Proto-Oncogene Proteins c-fos | 2 | 2015 | 583 | 0.200 |
Why?
|
Ganglionic Stimulants | 2 | 1999 | 18 | 0.200 |
Why?
|
Reperfusion Injury | 2 | 2024 | 1034 | 0.190 |
Why?
|
Blood-Brain Barrier | 1 | 2008 | 1034 | 0.190 |
Why?
|
Fibroblast Growth Factor 2 | 2 | 2001 | 595 | 0.190 |
Why?
|
Magnetic Resonance Imaging | 12 | 2024 | 36840 | 0.190 |
Why?
|
Vasodilator Agents | 1 | 2006 | 991 | 0.190 |
Why?
|
Organometallic Compounds | 2 | 2023 | 649 | 0.190 |
Why?
|
Gallium Radioisotopes | 1 | 2021 | 195 | 0.180 |
Why?
|
Spinal Cord | 5 | 2009 | 1814 | 0.180 |
Why?
|
Amyotrophic Lateral Sclerosis | 2 | 2009 | 1472 | 0.180 |
Why?
|
Lupus Nephritis | 1 | 2024 | 320 | 0.180 |
Why?
|
DNA Fragmentation | 1 | 2001 | 240 | 0.180 |
Why?
|
Tissue Distribution | 4 | 2023 | 2298 | 0.170 |
Why?
|
Superoxide Dismutase | 3 | 2008 | 596 | 0.170 |
Why?
|
Motor Neurons | 3 | 2009 | 872 | 0.160 |
Why?
|
Nitroarginine | 3 | 2006 | 66 | 0.160 |
Why?
|
Biological Factors | 1 | 2000 | 158 | 0.160 |
Why?
|
Aorta, Abdominal | 1 | 2021 | 627 | 0.160 |
Why?
|
Dilatation | 1 | 2000 | 311 | 0.150 |
Why?
|
Indomethacin | 3 | 2006 | 323 | 0.150 |
Why?
|
Electrodes, Implanted | 2 | 2015 | 841 | 0.150 |
Why?
|
Glycogen Phosphorylase | 1 | 2017 | 15 | 0.150 |
Why?
|
Oxidation-Reduction | 1 | 2024 | 2232 | 0.150 |
Why?
|
Rabbits | 2 | 2021 | 4786 | 0.140 |
Why?
|
Carotid Arteries | 1 | 2021 | 943 | 0.140 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2008 | 3520 | 0.140 |
Why?
|
Polymers | 1 | 2024 | 1631 | 0.140 |
Why?
|
Gadolinium | 4 | 2023 | 965 | 0.140 |
Why?
|
Disease Models, Animal | 6 | 2024 | 18388 | 0.140 |
Why?
|
Nicotine | 2 | 1999 | 681 | 0.130 |
Why?
|
Scorpion Venoms | 1 | 1996 | 30 | 0.130 |
Why?
|
Octoxynol | 2 | 2006 | 76 | 0.130 |
Why?
|
Nitric Oxide | 2 | 2006 | 2146 | 0.130 |
Why?
|
Migraine Disorders | 2 | 2020 | 1713 | 0.130 |
Why?
|
Organic Chemicals | 1 | 1996 | 211 | 0.120 |
Why?
|
Coordination Complexes | 1 | 2015 | 73 | 0.120 |
Why?
|
Respiratory Mechanics | 1 | 2019 | 722 | 0.120 |
Why?
|
Low Back Pain | 1 | 2023 | 989 | 0.120 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2001 | 1409 | 0.110 |
Why?
|
Brain Stem | 1 | 2019 | 862 | 0.110 |
Why?
|
Cyclooxygenase Inhibitors | 2 | 2006 | 361 | 0.110 |
Why?
|
Male | 26 | 2024 | 364781 | 0.100 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 2 | 2006 | 484 | 0.100 |
Why?
|
Analysis of Variance | 3 | 2011 | 6242 | 0.100 |
Why?
|
Chelating Agents | 1 | 2014 | 385 | 0.100 |
Why?
|
Locus Coeruleus | 1 | 2014 | 234 | 0.100 |
Why?
|
Blood Pressure | 3 | 2015 | 8538 | 0.100 |
Why?
|
Psychomotor Disorders | 1 | 2012 | 149 | 0.100 |
Why?
|
Recombinant Proteins | 4 | 2009 | 6527 | 0.100 |
Why?
|
Peptides | 3 | 2014 | 4368 | 0.100 |
Why?
|
Stroke | 3 | 2022 | 9791 | 0.090 |
Why?
|
Recombinant Fusion Proteins | 2 | 2009 | 3735 | 0.090 |
Why?
|
Ablation Techniques | 1 | 2012 | 249 | 0.080 |
Why?
|
Thrombosis | 3 | 2014 | 2956 | 0.080 |
Why?
|
Central Nervous System | 2 | 2008 | 1348 | 0.080 |
Why?
|
Muscle, Smooth, Vascular | 1 | 1996 | 1494 | 0.080 |
Why?
|
Vasoconstrictor Agents | 3 | 1998 | 658 | 0.080 |
Why?
|
Brain | 6 | 2024 | 27438 | 0.080 |
Why?
|
Mice, Knockout | 1 | 2024 | 14480 | 0.080 |
Why?
|
alpha-Galactosidase | 1 | 2008 | 58 | 0.080 |
Why?
|
Lac Operon | 1 | 2008 | 237 | 0.080 |
Why?
|
Random Allocation | 1 | 2012 | 2399 | 0.080 |
Why?
|
Drug Delivery Systems | 2 | 2009 | 2238 | 0.070 |
Why?
|
Neuroprotective Agents | 2 | 2006 | 960 | 0.070 |
Why?
|
Glycyrrhetinic Acid | 1 | 2006 | 15 | 0.070 |
Why?
|
Sumatriptan | 2 | 1996 | 66 | 0.070 |
Why?
|
Second Messenger Systems | 1 | 2006 | 204 | 0.060 |
Why?
|
Capsaicin | 1 | 2006 | 235 | 0.060 |
Why?
|
Mitomycin | 1 | 2005 | 264 | 0.060 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2021 | 9066 | 0.060 |
Why?
|
Behavior, Animal | 1 | 2012 | 1882 | 0.060 |
Why?
|
Functional Laterality | 1 | 2011 | 2268 | 0.060 |
Why?
|
Mice, Inbred MRL lpr | 1 | 2024 | 153 | 0.060 |
Why?
|
Perfusion | 2 | 2000 | 1402 | 0.060 |
Why?
|
Triazines | 1 | 2006 | 312 | 0.060 |
Why?
|
In Situ Nick-End Labeling | 2 | 2005 | 616 | 0.060 |
Why?
|
Guanylate Cyclase | 1 | 2004 | 206 | 0.050 |
Why?
|
Magnetic Resonance Angiography | 1 | 2010 | 1434 | 0.050 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2006 | 706 | 0.050 |
Why?
|
Carbazoles | 1 | 2004 | 221 | 0.050 |
Why?
|
Enzyme Inhibitors | 3 | 2006 | 3734 | 0.050 |
Why?
|
Motor Activity | 1 | 2012 | 2722 | 0.050 |
Why?
|
Valproic Acid | 1 | 2005 | 443 | 0.050 |
Why?
|
Mice | 9 | 2024 | 82045 | 0.050 |
Why?
|
Caspases | 2 | 2005 | 884 | 0.050 |
Why?
|
Electrodes | 1 | 2024 | 618 | 0.050 |
Why?
|
Protein Biosynthesis | 1 | 2009 | 2096 | 0.050 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2005 | 679 | 0.050 |
Why?
|
Potassium Channels | 1 | 2004 | 538 | 0.050 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2009 | 1943 | 0.050 |
Why?
|
Heterocyclic Compounds | 2 | 2014 | 245 | 0.050 |
Why?
|
Hypoxia-Ischemia, Brain | 1 | 2005 | 359 | 0.050 |
Why?
|
Manganese Compounds | 1 | 2021 | 25 | 0.050 |
Why?
|
Infarction | 1 | 2022 | 249 | 0.050 |
Why?
|
Microscopy, Fluorescence | 1 | 2008 | 2640 | 0.050 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2008 | 3816 | 0.050 |
Why?
|
Diamines | 1 | 2021 | 60 | 0.050 |
Why?
|
Picolinic Acids | 1 | 2021 | 50 | 0.050 |
Why?
|
Carrier Proteins | 1 | 2014 | 4948 | 0.050 |
Why?
|
Triazoles | 1 | 2006 | 905 | 0.040 |
Why?
|
Gadolinium DTPA | 1 | 2023 | 823 | 0.040 |
Why?
|
Caspase 1 | 1 | 2001 | 227 | 0.040 |
Why?
|
Rats, Sprague-Dawley | 3 | 2020 | 8201 | 0.040 |
Why?
|
bcl-2-Associated X Protein | 1 | 2001 | 282 | 0.040 |
Why?
|
Female | 12 | 2024 | 396943 | 0.040 |
Why?
|
Spodoptera | 2 | 2009 | 141 | 0.040 |
Why?
|
Mice, Inbred C57BL | 6 | 2024 | 22365 | 0.040 |
Why?
|
Recovery of Function | 1 | 2009 | 2994 | 0.040 |
Why?
|
Caspase 3 | 1 | 2001 | 732 | 0.040 |
Why?
|
Injections, Intravenous | 1 | 2001 | 1379 | 0.040 |
Why?
|
Data Interpretation, Statistical | 1 | 2008 | 2705 | 0.040 |
Why?
|
Leg | 1 | 2023 | 1089 | 0.040 |
Why?
|
Chromatography, High Pressure Liquid | 2 | 2013 | 1543 | 0.040 |
Why?
|
Injections, Intramuscular | 2 | 2009 | 557 | 0.040 |
Why?
|
Pyrroles | 1 | 2004 | 1127 | 0.040 |
Why?
|
Renal Artery | 1 | 1999 | 353 | 0.040 |
Why?
|
Phenylephrine | 1 | 1998 | 294 | 0.040 |
Why?
|
Brain Chemistry | 1 | 2001 | 962 | 0.040 |
Why?
|
Treatment Outcome | 3 | 2022 | 65409 | 0.030 |
Why?
|
Internal Mammary-Coronary Artery Anastomosis | 1 | 1996 | 38 | 0.030 |
Why?
|
Feasibility Studies | 2 | 2022 | 5308 | 0.030 |
Why?
|
Thromboxane-A Synthase | 1 | 1996 | 34 | 0.030 |
Why?
|
Pentanoic Acids | 1 | 1996 | 19 | 0.030 |
Why?
|
Severity of Illness Index | 2 | 2017 | 15965 | 0.030 |
Why?
|
Spine | 1 | 2023 | 1142 | 0.030 |
Why?
|
Indoles | 1 | 2004 | 1834 | 0.030 |
Why?
|
Muscle Relaxation | 1 | 1996 | 138 | 0.030 |
Why?
|
Mammary Arteries | 1 | 1996 | 82 | 0.030 |
Why?
|
Reproducibility of Results | 1 | 2014 | 20231 | 0.030 |
Why?
|
Fibrosis | 1 | 2023 | 2076 | 0.030 |
Why?
|
Serotonin Receptor Agonists | 1 | 1996 | 151 | 0.030 |
Why?
|
Receptors, Serotonin | 1 | 1996 | 209 | 0.030 |
Why?
|
Neurons | 3 | 2005 | 9504 | 0.030 |
Why?
|
Anticonvulsants | 1 | 2005 | 1923 | 0.030 |
Why?
|
Serotonin | 2 | 1996 | 1047 | 0.030 |
Why?
|
Heterocyclic Compounds, 1-Ring | 1 | 2014 | 68 | 0.030 |
Why?
|
Drug Stability | 1 | 2014 | 291 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 5 | 2006 | 10784 | 0.030 |
Why?
|
Down-Regulation | 1 | 2001 | 2944 | 0.030 |
Why?
|
Drug Interactions | 1 | 1998 | 1421 | 0.030 |
Why?
|
Membrane Glycoproteins | 1 | 2024 | 3713 | 0.030 |
Why?
|
Area Under Curve | 1 | 2017 | 1640 | 0.030 |
Why?
|
Nitric Oxide Synthase | 1 | 1996 | 911 | 0.030 |
Why?
|
Oxidative Stress | 1 | 2024 | 3145 | 0.030 |
Why?
|
Humans | 13 | 2024 | 768451 | 0.030 |
Why?
|
Cerebrovascular Disorders | 1 | 1999 | 1487 | 0.020 |
Why?
|
Molecular Structure | 1 | 2015 | 1889 | 0.020 |
Why?
|
Muscle Contraction | 1 | 1996 | 1208 | 0.020 |
Why?
|
Cerebral Hemorrhage | 1 | 2022 | 2665 | 0.020 |
Why?
|
Electric Stimulation | 1 | 2016 | 1743 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2014 | 20762 | 0.020 |
Why?
|
Animals, Newborn | 2 | 2006 | 2696 | 0.020 |
Why?
|
Cell Survival | 3 | 2006 | 5801 | 0.020 |
Why?
|
ROC Curve | 1 | 2017 | 3624 | 0.020 |
Why?
|
Aorta, Thoracic | 1 | 1996 | 1107 | 0.020 |
Why?
|
Models, Animal | 1 | 2016 | 2126 | 0.020 |
Why?
|
Baculoviridae | 1 | 2009 | 115 | 0.020 |
Why?
|
Time Factors | 2 | 2009 | 40271 | 0.020 |
Why?
|
Apoptosis | 2 | 2005 | 9526 | 0.020 |
Why?
|
Biological Availability | 1 | 2009 | 390 | 0.020 |
Why?
|
Injections, Spinal | 1 | 2009 | 318 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 1 | 2001 | 4534 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2022 | 12450 | 0.020 |
Why?
|
Blotting, Western | 2 | 2005 | 5042 | 0.020 |
Why?
|
Gene Expression Regulation | 1 | 2005 | 11930 | 0.020 |
Why?
|
Axotomy | 1 | 2006 | 71 | 0.020 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 1996 | 2279 | 0.020 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2017 | 2823 | 0.020 |
Why?
|
Injections, Intraventricular | 1 | 2005 | 227 | 0.020 |
Why?
|
Phosphopyruvate Hydratase | 1 | 2005 | 127 | 0.020 |
Why?
|
Electrocardiography | 1 | 2019 | 6410 | 0.020 |
Why?
|
Tyrosine 3-Monooxygenase | 1 | 2006 | 370 | 0.020 |
Why?
|
Lung | 1 | 2023 | 10090 | 0.010 |
Why?
|
Mesencephalon | 1 | 2006 | 339 | 0.010 |
Why?
|
Pyridines | 1 | 1996 | 2888 | 0.010 |
Why?
|
Mass Spectrometry | 1 | 2010 | 2204 | 0.010 |
Why?
|
Cell Line | 2 | 2009 | 15609 | 0.010 |
Why?
|
Immunohistochemistry | 2 | 2006 | 11138 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2017 | 14728 | 0.010 |
Why?
|
Cells, Cultured | 2 | 2009 | 19041 | 0.010 |
Why?
|
Cell Count | 1 | 2005 | 1835 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2009 | 6135 | 0.010 |
Why?
|
Thrombolytic Therapy | 1 | 2010 | 2058 | 0.010 |
Why?
|
Protein Transport | 1 | 2006 | 1963 | 0.010 |
Why?
|
Genetic Vectors | 1 | 2009 | 3417 | 0.010 |
Why?
|
Dopamine | 1 | 2006 | 1616 | 0.010 |
Why?
|
Nicotinic Antagonists | 1 | 1999 | 94 | 0.010 |
Why?
|
Radiography | 1 | 2010 | 6995 | 0.010 |
Why?
|
Prospective Studies | 1 | 2023 | 54914 | 0.010 |
Why?
|
Muscarinic Antagonists | 1 | 1999 | 135 | 0.010 |
Why?
|
Neuroblastoma | 1 | 2006 | 1265 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2005 | 4861 | 0.010 |
Why?
|
Methiothepin | 1 | 1996 | 1 | 0.010 |
Why?
|
Ketanserin | 1 | 1996 | 24 | 0.010 |
Why?
|
Molecular Weight | 1 | 1999 | 2173 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2009 | 9558 | 0.010 |
Why?
|
Hypertension | 1 | 1996 | 8611 | 0.010 |
Why?
|
Potassium Chloride | 1 | 1996 | 229 | 0.010 |
Why?
|
Serotonin Antagonists | 1 | 1996 | 144 | 0.010 |
Why?
|
United States | 1 | 2023 | 73121 | 0.010 |
Why?
|
Vasoconstriction | 1 | 1996 | 594 | 0.010 |
Why?
|
Vascular Patency | 1 | 1996 | 916 | 0.010 |
Why?
|
Neuroglia | 1 | 1999 | 961 | 0.010 |
Why?
|
Constriction, Pathologic | 1 | 1996 | 1103 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2017 | 59680 | 0.010 |
Why?
|
Disease Progression | 1 | 2009 | 13655 | 0.010 |
Why?
|
Young Adult | 1 | 2019 | 60045 | 0.010 |
Why?
|
Drug Evaluation, Preclinical | 1 | 1996 | 1339 | 0.010 |
Why?
|
Middle Aged | 3 | 2017 | 223418 | 0.000 |
Why?
|
Aged | 2 | 2017 | 171520 | 0.000 |
Why?
|
Adult | 2 | 2019 | 223542 | 0.000 |
Why?
|
Calcium | 1 | 1999 | 5793 | 0.000 |
Why?
|
Cell Differentiation | 1 | 1999 | 11674 | 0.000 |
Why?
|
Case-Control Studies | 1 | 1996 | 22293 | 0.000 |
Why?
|
Concepts
(261)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(33)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_